During a visit of Professor Dr Her Royal Highness Princess Chulabhorn Mahidol from Thailand to the UCL School of Pharmacy, research achievement and graduate training needs in the area of natural product science and biodiversity research were discussed. Professor Dr Her Royal Highness Princess Chulabhorn Mahidol from Thailand visited the UCL School of Pharmacy and [...]
A new drug to treat Morquio Syndrome, a rare life-limiting inherited disease, will be available on the Welsh NHS, Health and Social Services Minister Mark Drakeford has announced. The Minister has approved a recommendation from the All Wales Medicines Strategy Group (AWMSG) that Vimizim® (elosulfase alfa) should be available in Wales. Morquio Syndrome is a [...]
World-leading medicinal chemistry and biology at the Universities of Dundee and Cape Town have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge [...]
As a member of the Rare Disease Forum, the Association of the British Pharmaceutical Industry (ABPI) has welcomed the latest report and its recognition of the role the pharmaceutical industry plays in tackling the challenges of rare diseases, from research to new medicines for patients. The association also supports the implementation of the UK Strategy [...]
Television presenter – and former Rector of the University of Dundee – Lorraine Kelly has become the 100,000th volunteer to join a Scotland-wide effort to help shape the medicines of the future. SHARE (The Scottish Health Research Register) is a unique initiative which aims to make it easier for researchers to identify suitable recruits from Scotland [...]
Elsevier, a provider of scientific, technical and medical information products and services, has announced that it’s working with Findacure to identify drug repurposing candidates for the rare disease, Congenital Hyperinsulinism (CHI). Elsevier R&D Solutions will provide pro bono informatics expertise and advice, as well as access to published literature through its online tools for a [...]
Eisai and Charles River Laboratories have announced that they have signed a collaboration agreement which will see Charles River scientists work at Eisai's research and development facilities in Hatfield, UK. The collaboration will involve Charles River supporting Eisai scientists from Japan, USA and the UK on a range of synthetic and medicinal chemistry projects, including those seeking novel treatments for neurological diseases. [...]
Benepali (etanercept) has recently launched, providing prescribers with a biosimilar version of the TNF-targeting biologic etanercept. The 50mg prefilled pens and syringes are approved to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis in adults. Etanercept has been shown to slow the progression of joint damage and improve physical function in patients with rheumatoid [...]
New drugs created using enzymes from reef-dwelling marine organisms which may be used to fight cancer, inflammatory and auto-immune diseases, will be spearheaded by a new company formed from research carried out at the universities of Aberdeen and St Andrews. The two chemistry teams have developed a revolutionary new method for creating a new class [...]
The results of a project focused on early detection of people with undiagnosed coeliac disease have been published by Coeliac UK, the National Association of Primary Care and its primary care innovation network. The service targeted patients presenting with a minor ailment or a prescription which suggested that they may have undiagnosed coeliac disease. Pharmacy staff asked suitable [...]
